946 related articles for article (PubMed ID: 27451103)
1. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.
Possomato-Vieira JS; Khalil RA
Adv Pharmacol; 2016; 77():361-431. PubMed ID: 27451103
[TBL] [Abstract][Full Text] [Related]
2. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
Shah DA; Khalil RA
Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
[TBL] [Abstract][Full Text] [Related]
3. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.
Qu H; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H661-H681. PubMed ID: 32762557
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia.
Yu W; Gao W; Rong D; Wu Z; Khalil RA
Microcirculation; 2018 Oct; ():e12508. PubMed ID: 30338879
[TBL] [Abstract][Full Text] [Related]
5. Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.
Ali SM; Khalil RA
Expert Opin Ther Targets; 2015; 19(11):1495-515. PubMed ID: 26294111
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.
Chen J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():87-165. PubMed ID: 28662830
[TBL] [Abstract][Full Text] [Related]
7. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction.
Granger JP; Alexander BT; Llinas MT; Bennett WA; Khalil RA
Microcirculation; 2002 Jul; 9(3):147-60. PubMed ID: 12080413
[TBL] [Abstract][Full Text] [Related]
10. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors.
Tomimatsu T; Mimura K; Matsuzaki S; Endo M; Kumasawa K; Kimura T
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480243
[TBL] [Abstract][Full Text] [Related]
11. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models.
Khalil RA; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R29-45. PubMed ID: 12069928
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction.
Granger JP; Alexander BT; Llinas MT; Bennett WA; Khalil RA
Hypertension; 2001 Sep; 38(3 Pt 2):718-22. PubMed ID: 11566964
[TBL] [Abstract][Full Text] [Related]
13. Role of ADAM and ADAMTS disintegrin and metalloproteinases in normal pregnancy and preeclampsia.
Qu H; Khalil RA
Biochem Pharmacol; 2022 Dec; 206():115266. PubMed ID: 36191626
[TBL] [Abstract][Full Text] [Related]
14. Neurovascular mechanisms of hypertension in pregnancy.
Stennett AK; Khalil RA
Curr Neurovasc Res; 2006 May; 3(2):131-48. PubMed ID: 16719796
[TBL] [Abstract][Full Text] [Related]
15. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
[TBL] [Abstract][Full Text] [Related]
16. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.
Reslan OM; Khalil RA
Cardiovasc Hematol Agents Med Chem; 2010 Oct; 8(4):204-26. PubMed ID: 20923405
[TBL] [Abstract][Full Text] [Related]
17. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model.
Ushida T; Kotani T; Tsuda H; Imai K; Nakano T; Hirako S; Ito Y; Li H; Mano Y; Wang J; Miki R; Yamamoto E; Iwase A; Bando YK; Hirayama M; Ohno K; Toyokuni S; Kikkawa F
Free Radic Biol Med; 2016 Dec; 101():524-533. PubMed ID: 27789293
[TBL] [Abstract][Full Text] [Related]
18. [New insights in the pathophysiology of preeclampsia and potential therapeutic implications].
Boulanger H; Flamant M
Nephrol Ther; 2007 Dec; 3(7):437-48. PubMed ID: 18047998
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.
Sheppard SJ; Khalil RA
Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):33-52. PubMed ID: 20041838
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
